These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15998471)

  • 1. Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population.
    Al-Daghri N; Chetty R; McTernan PG; Al-Rubean K; Al-Attas O; Jones AF; Kumar S
    Cardiovasc Diabetol; 2005 Jul; 4():10. PubMed ID: 15998471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum resistin in acute myocardial infarction patients with and without diabetes mellitus.
    Korah TE; Ibrahim HH; Badr EA; ElShafie MK
    Postgrad Med J; 2011 Jul; 87(1029):463-7. PubMed ID: 21447495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.
    Yaturu S; Daberry RP; Rains J; Jain S
    Cytokine; 2006 May; 34(3-4):219-23. PubMed ID: 16822679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
    Nyström T; Nygren A; Sjöholm A
    Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between human serum resistin, inflammatory markers and insulin resistance.
    Bo S; Gambino R; Pagani A; Guidi S; Gentile L; Cassader M; Pagano GF
    Int J Obes (Lond); 2005 Nov; 29(11):1315-20. PubMed ID: 16044175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
    Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
    J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects.
    Mahadik SR; Deo SS; Mehtalia SD
    Metab Syndr Relat Disord; 2008 Jun; 6(2):121-8. PubMed ID: 18484906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.
    Habib SS
    Saudi Med J; 2012 May; 33(5):495-9. PubMed ID: 22588809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
    Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
    Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma resistin levels in asthmatics as a marker of disease state.
    Larochelle J; Freiler J; Dice J; Hagan L
    J Asthma; 2007 Sep; 44(7):509-13. PubMed ID: 17885852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease.
    Hamano M; Saito M; Eto M; Nishimatsu S; Suda H; Matsuda M; Matsuki M; Yamamoto S; Kaku K
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):125-9. PubMed ID: 15025802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics.
    Wu W; Li Q; Xia J; Wang M; Sun Z; Miao J; Zheng Z
    Hum Immunol; 2013 Mar; 74(3):379-82. PubMed ID: 23220502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
    Osawa H; Ochi M; Tabara Y; Kato K; Yamauchi J; Takata Y; Nishida W; Onuma H; Shimizu I; Fujii Y; Miki T; Ohashi J; Makino H
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):74-80. PubMed ID: 18081734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.